Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis  Matthew S. Shotwell, PhD, Phillip.

Similar presentations


Presentation on theme: "Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis  Matthew S. Shotwell, PhD, Phillip."— Presentation transcript:

1 Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis  Matthew S. Shotwell, PhD, Phillip N. Madonia, MD, Michael J. Connor, MD, Milen Amde, MD, Charbel Salem, MD, Olufemi A. Aduroja, MD, Seth R. Bauer, PharmD, Joseph J. Groszek, BS, William H. Fissell, MD  American Journal of Kidney Diseases  Volume 66, Issue 1, Pages (July 2015) DOI: /j.ajkd Copyright © 2015 National Kidney Foundation, Inc. Terms and Conditions

2 Figure 1 Ciprofloxacin serum concentration as a function of CRRT ciprofloxacin clearance. Filled circles, individual data points; line, linear regression estimate (P=0.02); grey area, 95% confidence region for regression line. CRRT ciprofloxacin clearance may exceed effluent flow rate, which is a consequence of the single-compartment model, which amalgamates intercompartmental and elimination clearances into a single value. American Journal of Kidney Diseases  , DOI: ( /j.ajkd ) Copyright © 2015 National Kidney Foundation, Inc. Terms and Conditions


Download ppt "Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis  Matthew S. Shotwell, PhD, Phillip."

Similar presentations


Ads by Google